India’s proposed US$5.4-billion “free medicine for all” policy promises to be a game-changer for the lives of millions of poor and vulnerable people, many of whom cannot afford their medications or are not being reached by public health facilities…And as with a recent decision by the government of India to issue its first patent compulsory licensing order ,it is expected to have major ramifications for the pharmaceutical market. The free medicines will be generics. Doctors working in health facilities will be required to prescribe generic drugs listed on state-determined “essential drug lists”. Continue reading the entire article by Dr. Soumyadeep B at Canadian Medical Association Journal (Open Access)
Dr. Soumyadeep Bhaumik 
2 Comments